40
https://pubmed.ncbi.nlm.nih.gov/38094744
This study suggests that while both amplification-based and amplification-free metagenomic next-generation sequencing (mNGS) tests show promise in diagnosing infectious diseases, they have specific advantages and disadvantages, and their clinical application requires further methodological exploration for optimal performance and accuracy in guiding antibiotic use.